Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

CLEVELAND, Ohio — Patients with Type 1 diabetes have lost the specialized pancreatic cells that produce insulin, putting them ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Greetings Plainview! Your go-to source for what's happening in town is here. Stay in the loop and read on. ☀️ In today's newsletter: Also on today's calendar: Treatment Options for Tremor and 9 more ...

A BMJ guideline put patient risk into the equation for assessing the suitability of SGLT-2 inhibitors and GLP-1 receptor agonist drugs for type 2 diabetes. Their use in type 2 diabetes was only ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...